News|Articles|March 15, 2024
NeurologyLive® Friday 5 — March 15, 2024
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 15, 2024.
Advertisement
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: FDA Action Update, February 2024: Clearance, Priority Review, and Designation
The FDA was busy in February 2024, making a number of decisions on potential new therapeutic agents including a clearance for a clinical trial, granting a priority review for efficacy supplement, and granting a fast track designation.
2: Raising Awareness for the Lasting Effects of Traumatic Brain Injury: Shae Datta, MD
The neurologist and migraine expert at NYU Langone Health provided perspective on TBI Awareness Month and the importance of accurate detection and swift care for trauamatic brain injury. [WATCH TIME: 4 minutes]
3: Navigating the Shift from Pediatric to Adult Care Systems in Epilepsy: Danielle Andrade, MD, MSc, FRCPC
The director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the critical issues experienced by patients who transition from pediatric to adult care in epilepsy. [WATCH TIME: 9 minutes]
4: NeuroVoices: Michael S. Okun, MD, on the Potential Benefit of Continuous Physical Therapy in Parkinson Disease
In this week's NeuroVoices Q&A, the national medical advisor for the Parkinson's Foundation discussed the importance of continuous and ‘spaced’ physical therapy for Parkinson disease, highlighting the underutilization of this approach.
5: Wearable Devices in Parkinson’s Disease (PD)
In episode 1 of the "Device-Aided Management of Parkinson's Disease" video series, Zoltan Mari, MD, leads a discussion on the benefits of wearable devices in Parkinson Disease, and emphasizes the major public health impact of the disease.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
3
NeurologyLive® Friday 5 — September 12, 2025
4
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
5